Skip Nav Destination
Abstract A088: Novel anti-EGFR antibody-drug conjugate AVID100: A phase 2a trial in patients with EGFR-overexpressing advanced solid tumors
Mol Cancer Ther (2019) 18 (12_Supplement): A088.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Nan Chen
- Elena Michaels
- Frederick Howard
- Rita Nanda
Expert Review of Anticancer Therapy (2022) 22 (12): 1325.
RSS Feeds